About EBC-46

How Does It Work

EBC-46 is delivered in a single treatment by direct injection into tumours, or by topical application of a gel onto the tumour surface, and works by stimulating the patient’s innate immune system to destroy the tumour.

EBC-46 is potentially useful in treating any solid tumour that can be accessed for direct injection of the drug into the tumour. Essentially, any tumour that can be biopsied is amenable for treatment with the drug.


Home

About QBiotics

Snapshot

Business Structure

Our Business Overview

Mission

Strategy

Milestones

Corporate Responsibility

Values & Culture

Governance

Natural Environment

In The Community

About EBC-46

What Is EBC-46

How Does It Work

EBC-46 Discovery

Development

EBC-46 Results

Results

Case Studies

Photo Gallery

Our Team

Board & Management

Research & Development

Partners

Media

Video

Press

Latest News

Media Enquiries

Investors

Register For Upcoming Offers

Download Our Corporate Profile

EBC-46 & Animals

Clinical Trials

Enquiries

EBC-46 & Humans

Clinical Trials

Enquiries

FAQ

Newsletter

Newsletter Sign up

Contact Us

General Enquiries

EBC-46 & Animals

Clinical Trail Enquiries

Media Enquiries